Katharina Schlett | Fieldfisher
Skip to main content
Professional background

Professional background

My main areas of practice


My clients include national and international companies. Furthermore, I advise pharmaceutical companies and manufacturers of medical devices in regulatory matters and negotiate and draft various types of contracts in the field of life sciences.

I enjoy spending my free time with family and friends. Sport, especially tennis and skiing, keeps me fit and jogging provides me with the necessary balance to my daily work.
 

Authored pieces

All Resources
A digital illustration of a DNA double helix with a glowing purple and blue color scheme. Surrounding the DNA strand are interconnected lines and points forming a geometric network. The background is a dark gradient, enhancing the vibrant colors and the futuristic aesthetic.
Insight

Current guidelines from the Federal Court of Justice regarding the German Act on Advertising in the Healthcare Sector

22.04.2026
The Federal Court of Justice (BGH) has issued two rulings addressing central issues related to telemedicine and advertising law. This is especially relevant for companies in the online health services sector. 
Learn more
Abstract representation of a chemical structure on a gradient purple and blue background. The molecular diagram features various bonded elements and hexagonal shapes, highlighting nitrogen (N) and amine (NH) groups.
Life Sciences
Insight

Small Gifts, Strict Rules: What the One-Euro Limit Means for Product-Related Advertising in the German MedTech Industry

25.07.2025
Learn more
A digital representation of a DNA double helix, with glowing particles forming the iconic twisted ladder shape. The background is a gradient of blue and purple, giving a futuristic and scientific feel to the image.
Insight

Update on the new Art. 10a MDR

10.12.2024
Learn more
Close-up of multiple pipettes dispensing blue liquid into rows of small, transparent test tubes in a laboratory setting. The scene is well-lit, emphasizing the precision and sterility of the scientific equipment and process.
Life Sciences
Insight

New MDR/IVDR amendment: transitional provisions for IVDs, EUDAMED, new Art. 10a

06.08.2024
Learn more
Life Sciences
Insight

Artificial Intelligence and Medical Devices – Compliance with the AI Act

02.08.2024
Learn more